High materiality7/10
Rothschild Redburn Upgrades Abbott Labs (ABT) to Buy
Why it may matterVerify against the original reporting
Upside potential supported by upgrade.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Target 127; posted price 96.71; bullish setup.
- Target 127 vs price 96.71; bullish.
Key facts
- 01
Target: $127
- 02
Posted price: $96.71
- 03
Analyst firm: Redburn Partners
- 04
Analyst: Ed Ridley-Day
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.